Copyright
©The Author(s) 2017.
World J Hepatol. Sep 8, 2017; 9(25): 1073-1080
Published online Sep 8, 2017. doi: 10.4254/wjh.v9.i25.1073
Published online Sep 8, 2017. doi: 10.4254/wjh.v9.i25.1073
Characteristics | Group 1 | Group 2 | Control | P value |
n = 11 | n = 13 | n = 5 | ||
Age (yr)1 | 46.3 (3.9) | 52.2 (4.5) | 31 (4.8) | 0.02 |
Male/female | 9/2 | 11/2 | 3/2 | 0.85 |
CD4 cell count1 | 770 (205) | 521 (312) | 910 (251) | 0.03 |
CD8 cell count1 | 1079 (475) | 657 (339) | NA | 0.24 |
METAVIR F0-F2 | 100% | 0 | 100% | NC |
METAVIR F3-F4 | 0 | 100% | 0 | NC |
TGP1 | 79.7 (74.2) | 99 (71.4) | NA | 0.41 |
Time of known HIV infection1 | 18 (6.52) | 17.3 (3.8) | NC | 0.60 |
Time of known HCV infection1 | 14.3 (7.0) | 13.8 (4.6) | NC | 0.65 |
- Citation: Laufer N, Ojeda D, Polo ML, Martinez A, Pérez H, Turk G, Cahn P, Zwirner NW, Quarleri J. CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients. World J Hepatol 2017; 9(25): 1073-1080
- URL: https://www.wjgnet.com/1948-5182/full/v9/i25/1073.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i25.1073